Myoelectric SoftHand Pro to Improve Prosthetic Function for People With Below-elbow Amputations: A Feasibility Study
SoftHand
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
A study to investigate the hypothesis that a Pisa/IIT Robotic SoftHand Pro converted to a prosthetic terminal device will enhance the performance of people with limb loss in a wider range of daily living tasks than allowed by today's commercially available prosthetic hands, and will exceed established benchmarks for activities of daily living (ADL).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2014
CompletedFirst Posted
Study publicly available on registry
October 24, 2014
CompletedStudy Start
First participant enrolled
October 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2016
CompletedJanuary 18, 2018
January 1, 2018
1.6 years
October 22, 2014
January 16, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Functional assessments
DASH score, the Jebsen Taylor Test of Hand Function, and biomechanical measures (including total grip force, load force sharing between the thumb and finger(s), time to peak grip force, and net torque exerted by the subject at object lift onset).
1 week
Secondary Outcomes (1)
ADL tests
1 week
Study Arms (2)
Patient
EXPERIMENTALTesting will include self-report questionnaires, assessments of activities of daily living (ADL) by an occupational therapist, and biomechanical measures of forces applied to objects and motion of the upper limb collected during commonly-performed tasks. Motion will be recorded using sensors that are attached to the arm and SoftHand. During each session, videos will be obtained of the subjects performing tasks. The experimental data collections are organized into 5 Sessions, which will take place over the course of 1 week, scheduled by the subject's availability, with the option with patients for a 1-week period of take-home testing and associated pre- and post-assessments.
Control
OTHERTesting will include self-report questionnaires, assessments of activities of daily living (ADL) by an occupational therapist, and biomechanical measures of forces applied to objects and motion of the upper limb collected during commonly-performed tasks. Motion will be recorded using sensors that are attached to the arm and SoftHand. During each session, videos will be obtained of the subjects performing tasks. The experimental data collections are organized into 4 Sessions, which will take place over the course of 1 week, scheduled by the subject's availability. Control subjects will participate in two sessions, including a pre- and post-training assessments.
Interventions
Eligibility Criteria
You may qualify if:
- \) Subjects \> 18 years of age.
You may not qualify if:
- Patients with an amputation for less than 6 months.
- Patients who have been fit and trained to use a prothesis but chose not to do so.
- Clinical history of brachial plexopathy, cervical radiculopathy or polyneuropathy and persistent weakness.
- \) Visual problems that would interfere with our grasp task.
- \) Co-existing central nervous system disease (e.g., multiple sclerosis, motor neuron disease, myasthenia gravis, Parkinson's disease, dystonia) that would interfere with our grasp task
- \) Significant spasticity/rigidity as assessed through range of motion testing that would interfere with our grasp task.
- \) Active psychiatric illness.
- \) Cognitive impairments which would interfere with following study instructions and filling out surveys (at the investigator's discretion).
- \) Use of medications that might affect sensory and/or motor functions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karen L. Andrews, M.D.lead
- Arizona State Universitycollaborator
- University of Pisacollaborator
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Karen L. Andrews, M.D.
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Physical Medicine & Rehab
Study Record Dates
First Submitted
October 22, 2014
First Posted
October 24, 2014
Study Start
October 24, 2014
Primary Completion
May 17, 2016
Study Completion
May 17, 2016
Last Updated
January 18, 2018
Record last verified: 2018-01